Meet ApplyKite Twin, the application assistant that learns with you
Meet your Twin, it learns with you
Your Twin learns with you
Launch week codes:30% off annual Pro20% off monthly Pro
Ends in00h00m00s
Ends in00h00m00s
Sonia Caccia
Has grant
Docenti
Research Interests
Explore related searches
Recent Grants
Grant: Close
Molecular and Cellular Bases of Serpin Conformational Diseases
Open Date: 2013-01-01
Close Date:
Grant: Close
The role of neuroserpin in Familial Encephalopathy with Neuroserpin Inclusion Bodies (FENIB)
Open Date: 2011-01-01
Close Date: 2014-01-01
Grant: Close
Gene regulation in the pathogenesis of angioedema due to inherited C1 inhibitor deficiency (Hereditary angioedema)
Open Date: 2008-01-01
Close Date: 2011-01-01
Articles (9)
Year:
2026
Year:
2026
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Background: Platelet “Microvesicles” (MVs) are studied for their role in blood coagulation and inflammation. The study aimed to establish if MVs are related to age, plasma levels of inflammation, coagulation, and fibrinolysis markers in healthy individuals. Methods: We prospectively enrolled volunteers aged over 18 years. MVs, plasma levels of C-reactive protein (CRP), Interleukin 6 (IL-6), Interleukin 10 (IL-10), Interleukin 17 (IL-17), and transforming growth factor β (TGF-β), fibrinogen, plasminogen activator inhibitor-1 (PAI-1), von Willebrand factor (VWF), homocysteine, factor VII (FVII), thrombin activatable fibrinolysis inhibitor (TAFI), and Protein S were tested. Results: A total of 246 individuals (median age 65 years (“IQR”54–72)) were evaluated. Both univariate analysis and logistic regression models showed that MVs positively correlate with age, CRP, IL-6, IL-10, IL-17, TGF-β, fibrinogen, PAI-1, VWF, FVII, and homocysteine, while inversely correlating with TAFI and Protein S. The ROC curve analysis performed to identify a cut off for MV values (700 kMP) showed a good accuracy with over-range cytokines fibrinolysis factor and coagulation markers. Conclusions: To the best of our knowledge, this study is the first to correlate MVs with an entire panel of cardiovascular risk factors in healthy individuals. A future possible role of MVs in screening exams is suggested.
Year:
2023
Year:
2022
Collaborators (25)
Stefan Erkeland
Associate professor (UHD)
Erasmus MC
Peter Katsikis
Professor & Head
Erasmus University Medical Center
Isabella Friis Jørgensen
Københavns Universitet
Luca Cantarini
Associate Professor of Rheumatology
University of Siena
Rosanna Asselta
Full Professor in Medical Genetics
Humanitas University
Roberto Manetti
University of Sassari
Paolo Sfriso
Docenti di ruolo di IIa fascia
University of Padova
Sophie Georgin-Lavialle
Full professor of internal medicine
Sorbonne Université
Sinisa Savic
Professor of Clinical immunology
University of Leeds
Patrick Matthys
PI, Professor
KU Leuven
Argiris Symeonidis
Professor of Hematology, Head of the Department
University of Patras School of Medicine
Roberto Castelli
-
Yvonne Mueller
Assistant professor
Erasmus University Medical Center
Clementien Vermont
Researcher
Erasmus University Rotterdam
Sara Ludovico Garcia
Københavns Universitet
Fiona Limanaqi
Associate Professor in Human Anatomy
University of Milan
Thomas Henry
PI
Université Claude Bernard Lyon 1
Philippe Hupe
PSL Research University
Harmen van de Werken
Assistant Professor Computational Biology & Bioinformatics at the Department of Immunology
Erasmus MC
Silvia Berra
Università degli Studi di Torino
Christophe Poulet
Associate Professor
University of Liege
Carine Wouters
Professor
University Hospitals Leuven
Paul van Daele
Erasmus University Rotterdam
Paul Proost
principle investigator
Katholieke Universiteit Leuven
Michael F. McDermott
Professor of Experimental Rheumatology
University of Galway
Make your next move.
Prepare your application
Review drafts before you send them.